233 related articles for article (PubMed ID: 16271945)
1. New antiarrhythmic drugs for prevention of atrial fibrillation.
Goldstein RN; Stambler BS
Prog Cardiovasc Dis; 2005; 48(3):193-208. PubMed ID: 16271945
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.
Camm J
Int J Cardiol; 2012 Mar; 155(3):362-71. PubMed ID: 21708411
[TBL] [Abstract][Full Text] [Related]
3. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
Savelieva I; Kakouros N; Kourliouros A; Camm AJ
Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
[TBL] [Abstract][Full Text] [Related]
4. [Antiarrhythmic drugs in paroxysmal atrial fibrillation. When and how?].
Lévy S; Ricard P; Yapo F; Mansouri C
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():19-24. PubMed ID: 8734159
[TBL] [Abstract][Full Text] [Related]
5. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Savelieva I; Camm J
Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
[TBL] [Abstract][Full Text] [Related]
6. Atrial structural remodeling as an antiarrhythmic target.
Burstein B; Nattel S
J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
[TBL] [Abstract][Full Text] [Related]
7. The future of atrial fibrillation therapy.
Dorian P
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S11-6. PubMed ID: 16939433
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy for atrial fibrillation.
Musco S; Conway EL; Kowey PR
Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
[TBL] [Abstract][Full Text] [Related]
9. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs.
Shiroshita-Takeshita A; Sakabe M; Haugan K; Hennan JK; Nattel S
Circulation; 2007 Jan; 115(3):310-8. PubMed ID: 17224477
[TBL] [Abstract][Full Text] [Related]
10. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
Chávez LL
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
[TBL] [Abstract][Full Text] [Related]
11. Cardioversion for atrial fibrillation: treatment options and advances.
Reiffel JA
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1073-84. PubMed ID: 19659629
[TBL] [Abstract][Full Text] [Related]
12. The Past, Present, and Potential Future of Sodium Channel Block as an Atrial Fibrillation Suppressing Strategy.
Aguilar M; Nattel S
J Cardiovasc Pharmacol; 2015 Nov; 66(5):432-40. PubMed ID: 25923324
[TBL] [Abstract][Full Text] [Related]
13. New pharmacological targets and treatments for atrial fibrillation.
Carlsson L; Duker G; Jacobson I
Trends Pharmacol Sci; 2010 Aug; 31(8):364-71. PubMed ID: 20605645
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic approaches to rhythm versus rate control in atrial fibrillation--where are we now?
Wyse DG
Int J Cardiol; 2006 Jun; 110(3):301-12. PubMed ID: 16516313
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of atrial fibrillation.
Miranda RI; Simpson CS; Michael KA; Abdollah H; Baranchuk AM; Redfearn DP
Minerva Cardioangiol; 2010 Dec; 58(6):637-48. PubMed ID: 21135805
[TBL] [Abstract][Full Text] [Related]
16. Drug therapy for atrial fibrillation.
Conway EL; Musco S; Kowey PR
Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and the expanding role of catheter ablation: do antiarrhythmic drugs have a future?
Naccarelli GV; Gonzalez MD
J Cardiovasc Pharmacol; 2008 Sep; 52(3):203-9. PubMed ID: 18806600
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation: insights from clinical trials and novel treatment options.
Blaauw Y; Crijns HJ
J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
[TBL] [Abstract][Full Text] [Related]
19. Novel pharmacological therapies for atrial fibrillation.
Bagwe S; Leonardi M; Bissett J
Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blockers in the prevention of atrial fibrillation.
Barra S; Silvestri N; Vitagliano G; Madrid A; Gaeta G
Expert Opin Pharmacother; 2009 Jun; 10(9):1395-411. PubMed ID: 19466911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
